Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Dec;74(6):2290–2295. doi: 10.1172/JCI111657

L-carnitine therapy in isovaleric acidemia.

C R Roe, D S Millington, D A Maltby, S G Kahler, T P Bohan
PMCID: PMC425423  PMID: 6549017

Abstract

Isovaleric acidemia, resulting from isovaleryl-coenzyme A dehydrogenase deficiency, is associated with marked reduction of free carnitine in both plasma and urine. Fast atom bombardment-mass spectrometry, hydrolysis, and gas chromatography/mass spectrometry have unequivocally identified the existence of isovalerylcarnitine, a new metabolite specific for this disorder. Administration of equimolar amounts of glycine or L-carnitine separately with leucine demonstrated that isovaleryl-coenzyme A is removed by supplemental L-carnitine in the form of isovalerylcarnitine as effectively as it is by glycine, in the form of isovalerylglycine. When L-carnitine is given alone, excretion of isovalerylglycine decreases in preference to enhanced excretion of isovalerylcarnitine and hippurate. Treatment with L-carnitine alone has proven effective in preventing further hospitalizations in a patient with this genetic disorder.

Full text

PDF
2291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett K., Gompertz D. The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias. Biochem Med. 1974 May;10(1):15–23. doi: 10.1016/0006-2944(74)90004-0. [DOI] [PubMed] [Google Scholar]
  2. Bohmer T., Bremer J. Propionylcarnitine. Physiological variations in vivo. Biochim Biophys Acta. 1968 May 1;152(3):559–567. doi: 10.1016/0005-2760(68)90096-9. [DOI] [PubMed] [Google Scholar]
  3. Brass E. P., Hoppel C. L. Carnitine metabolism in the fasting rat. J Biol Chem. 1978 Apr 25;253(8):2688–2693. [PubMed] [Google Scholar]
  4. Budd M. A., Tanaka K., Holmes L. B., Efron M. L., Crawford J. D., Isselbacher K. J. Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism. N Engl J Med. 1967 Aug 17;277(7):321–327. doi: 10.1056/NEJM196708172770701. [DOI] [PubMed] [Google Scholar]
  5. Cohn R. M., Yudkoff M., Rothman R., Segal S. Isovaleric acidemia: use of glycine therapy in neonates. N Engl J Med. 1978 Nov 2;299(18):996–999. doi: 10.1056/NEJM197811022991807. [DOI] [PubMed] [Google Scholar]
  6. Krieger I., Tanaka K. Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res. 1976 Jan;10(1):25–29. doi: 10.1203/00006450-197601000-00005. [DOI] [PubMed] [Google Scholar]
  7. Millington D. S., Roe C. R., Maltby D. A. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom. 1984 May;11(5):236–241. doi: 10.1002/bms.1200110508. [DOI] [PubMed] [Google Scholar]
  8. Roe C. R., Bohan T. P. L-carnitine therapy in propionicacidaemia. Lancet. 1982 Jun 19;1(8286):1411–1412. doi: 10.1016/s0140-6736(82)92524-7. [DOI] [PubMed] [Google Scholar]
  9. Roe C. R., Hoppel C. L., Stacey T. E., Chalmers R. A., Tracey B. M., Millington D. S. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child. 1983 Nov;58(11):916–920. doi: 10.1136/adc.58.11.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Roe C. R., Millington D. S., Maltby D. A., Bohan T. P., Hoppel C. L. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest. 1984 Jun;73(6):1785–1788. doi: 10.1172/JCI111387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tanaka K., Budd M. A., Efron M. L., Isselbacher K. J. Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci U S A. 1966 Jul;56(1):236–242. doi: 10.1073/pnas.56.1.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tanaka K., Isselbacher K. J. The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia. J Biol Chem. 1967 Jun 25;242(12):2966–2972. [PubMed] [Google Scholar]
  13. Valkner K. J., Bieber L. L. Short-chain acylcarnitines of human blood and urine. Biochem Med. 1982 Oct;28(2):197–203. doi: 10.1016/0006-2944(82)90070-9. [DOI] [PubMed] [Google Scholar]
  14. Yudkoff M., Cohn R. M., Puschak R., Rothman R., Segal S. Glycine therapy in isovaleric acidemia. J Pediatr. 1978 May;92(5):813–817. doi: 10.1016/s0022-3476(78)80164-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES